Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Pathol ; 189(2): 279-87, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10547587

RESUMEN

The expression of collagen type IV chains in the renal tubulointerstitium was investigated during the development of chronic serum sickness (CSS) in rats, a model for immune complex-mediated renal disease. Immunohistochemical studies showed increased expression of alpha4(IV) collagen early during disease development, followed by an increase in alpha1(IV) through alpha3(IV) collagen subchain expression, especially in the tubular basement membrane. Dot-blot and in situ hybridization analysis showed a transient increase in steady-state mRNA levels for all collagen IV subchains during the development of CSS, which was most abundant for alpha1(IV), alpha2(IV), and alpha4(IV). Statistical correlations were found between the mRNA levels of alpha1(IV) and alpha2(IV) collagen and between alpha3(IV) and alpha4(IV), in line with the results of others which showed that these chains are co-distributed as heterotrimer collagen type IV molecules. However, additional correlations were found between the mRNA levels coding for alpha1(IV) and alpha3(IV) collagen, and between alpha1(IV) and alpha4(IV) mRNAs in the course of CSS. These abnormal correlations support the hypothesis that changes occur in the co-expression of the collagen IV subchains during the development of CSS. In addition, a strong correlation was found between the presence in the tubulointerstitium of alpha1(IV) and alpha2(IV) collagen chains, on the one hand, and the tubulointerstitial influx of R73+ and ED1+ cells, on the other, suggesting the involvement of inflammatory cells in the observed alterations in matrix production. Changes in the relative abundance of collagen IV chains in disease states may perturb the collagen IV network in the tubulointerstitial compartment and thereby play a role in the development of renal failure.


Asunto(s)
Colágeno/metabolismo , Glomerulonefritis/metabolismo , Túbulos Renales/metabolismo , Enfermedad del Suero/metabolismo , Animales , Enfermedad Crónica , Colágeno/genética , Femenino , Expresión Génica , Técnicas para Inmunoenzimas , Hibridación in Situ , ARN Mensajero/genética , Ratas , Ratas Wistar
2.
J Lab Clin Med ; 130(4): 357-64, 1997 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-9358073

RESUMEN

The purpose of this article is to review a set of recently obtained data concerning matrix and matrix adhesion molecules in renal disease. Our goal is not to cover the entire topic, but rather to focus on findings obtained with an experimental model for chronic lupus nephritis, evoked in mice by inducing graft-versus-host disease (GVHD). The overall aim of these studies was to investigate the role of adhesion molecules as targets for autoantibodies, in the recruitment of inflammatory cells, and in the accumulation of matrix in kidney disorders. In addition, we set out to discover how matrix proteins in renal diseases differ from normal matrix molecules both quantitatively, in their increased frequency, and qualitatively, in their intramolecular structure. The advances in understanding and methodology described in this review imply a substantial capability for greater insight into the pathogenesis of kidney disease; for making better use of renal biopsies, such as in applying competitive reverse-transcriptase-polymerase chain reaction (RT-PCR) in RNA analysis for matrix; and in developing more effective treatment strategies for patients with kidney disease.


Asunto(s)
Moléculas de Adhesión Celular/metabolismo , Proteínas de la Matriz Extracelular/metabolismo , Matriz Extracelular/metabolismo , Glomérulos Renales/patología , Nefritis Lúpica/metabolismo , Nefritis Lúpica/patología , Animales , Autoanticuerpos/inmunología , Moléculas de Adhesión Celular/química , Moléculas de Adhesión Celular/inmunología , Modelos Animales de Enfermedad , Matriz Extracelular/inmunología , Matriz Extracelular/patología , Proteínas de la Matriz Extracelular/química , Proteínas de la Matriz Extracelular/inmunología , Enfermedad Injerto contra Huésped/inmunología , Humanos , Glomérulos Renales/inmunología , Glomérulos Renales/metabolismo , Nefritis Lúpica/inmunología , Ratones
3.
J Immunol ; 158(3): 1458-65, 1997 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-9013992

RESUMEN

In rheumatoid arthritis (RA), T cells isolated from the synovial fluid (SF) show impaired responses to mitogenic stimulation compared with T cells from the peripheral blood (PB). Here it is reported that hyporesponsiveness of SF T cells correlated with a significant decrease in the levels of the intracellular redox-regulating agent glutathione (GSH). GSH was decreased in both CD4+ (p = 0.0022) and CD8+ (p = 0.0010) SF T cell subsets compared with PB CD4+ and CD8+ T cells in RA patients. Levels of thioredoxin (TRX), another key redox mediator, previously found to be secreted under conditions of oxidative stress, were found to be significantly increased in SF compared with plasma samples of RA patients (p = 0.005). Increased levels of TRX in the SF of inflamed joints was found to be associated with RA when compared with other arthritides (p = 0.007). Restoration of GSH levels in SF T cells with N-acetyl-L-cysteine (NAC), enhanced mitogenic induced proliferative responses and IL-2 production. Collectively, these data impute an important role to an altered redox state in the hyporesponsiveness of joint T cells in patients with RA.


Asunto(s)
Artritis Reumatoide/inmunología , Glutatión/metabolismo , Líquido Sinovial/inmunología , Linfocitos T/metabolismo , Adulto , Anciano , Artritis Reumatoide/metabolismo , Femenino , Humanos , Activación de Linfocitos , Masculino , Persona de Mediana Edad , Osteoartritis/inmunología , Osteoartritis/metabolismo , Oxidación-Reducción , Subgrupos de Linfocitos T/metabolismo , Tiorredoxinas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA